Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Activity to Breast Cancer Cell Lines of Different Malignancy and Predicted Interaction with Protein Kinase C Isoforms of Royleanones (CROSBI ID 286944)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Isca, Vera M. S. ; Sencanski, Milan ; Filipovic, Nenad ; Dos Santos, Daniel J. V. A. ; Čipak Gašparović, Ana ; Saraíva, Lucília ; Afonso, Carlos A. M. ; Rijo, Patrícia ; García-Sosa, Alfonso T. Activity to Breast Cancer Cell Lines of Different Malignancy and Predicted Interaction with Protein Kinase C Isoforms of Royleanones // International journal of molecular sciences, 21 (2020), 10; 3671, 17. doi: 10.3390/ijms21103671

Podaci o odgovornosti

Isca, Vera M. S. ; Sencanski, Milan ; Filipovic, Nenad ; Dos Santos, Daniel J. V. A. ; Čipak Gašparović, Ana ; Saraíva, Lucília ; Afonso, Carlos A. M. ; Rijo, Patrícia ; García-Sosa, Alfonso T.

engleski

Activity to Breast Cancer Cell Lines of Different Malignancy and Predicted Interaction with Protein Kinase C Isoforms of Royleanones

Plants have been used for centuries to treat several illnesses. The Plectranthus genus has a vast variety of species that has allowed the isolation of cytotoxic compounds with notable activities. The abietane diterpenes 6, 7-dehydroroyleanone (DeRoy, 1), 7α-acetoxy-6β-hydroxyroyleanone (Roy, 2), and Parvifloron D (ParvD, 3) were obtained from Plectranthus spp. and showed promising biological activities, such as cytotoxicity. The inhibitory effects of the different natural abietanes (1-3) were compared in MFC7, SkBr3, and SUM159 cell lines, as well as SUM159 grown in cancer stem cell-inducing conditions. Based on the royleanones’ bioactivity, the derivatives RoyBz (4), RoyBzCl (5), RoyPr2 (6), and DihydroxyRoy (7), previously obtained from 2, were selected for further studies. Protein kinases C (PKCs) are involved in several carcinogenic processes. Thus, PKCs are potential targets for cancer therapy. To date, the portfolio of available PKC modulators remains very limited due to the difficulty of designing isozyme-selective PKC modulators. As such, molecular docking was used to evaluate royleanones 1-6 as predicted isozyme-selective PKC binders. Subtle changes in the binding site of each PKC isoform change the predicted interaction profiles of the ligands. Subtle changes in royleanone substitution patterns, such as a double substitution only with non-substituted phenyls, or hydroxybenzoate at position four that flips the binding mode of ParvD (3), can increase the predicted interactions in certain PKC subtypes

royleanones ; hemi-synthesis ; PKC activity ; isozyme-selectivity ; molecular interactions

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

21 (10)

2020.

3671

17

objavljeno

1422-0067

10.3390/ijms21103671

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost